Day: October 2, 2024

Good Housekeeping’s trusted home renovation guide recognizes Sunrun’s solar-plus-storage subscription service for helping families protect against rising energy costs and power outages SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, announced today that its home solar-plus-storage subscription service was named a Sustainability Innovator in Good Housekeeping’s 2025 Home Renovation Awards. “Our customers crave the feeling of independence and security that comes from being protected from power outages and—in many areas across the country—double-digit utility rate increases,” said Sunrun CEO Mary Powell. “Our subscription service is the ultimate home renovation upgrade because it adds immediate value to your home and life. Making energy...

LONG BEACH, Calif. and TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company“) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically integrated cannabis businesses in the U.S. today announced that Graham Farrar, Co-founder, Board Member and President, and Mark Vendetti, Chief Financial Officer will participate at the Benzinga Cannabis Capital Conference being held October 8-9, 2024, in Chicago. Mr. Farrar will participate in the panel discussion “How To Leverage Emerging Technologies To Drive Cannabis Supply Chain Efficiencies” moderated by Barbara Fox, CEO of Cannabiz Supply, on Wednesday, October 9th, 2024 at 11:30 am CT. Mr. Vendetti will participate in the VIP Roundtable “Cannabis Capital...

ZEELAND, Minn., Oct. 02, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, and fire protection technologies, is pleased to announce that it will release its third quarter 2024 financial results on Friday, October 25, before the market opens. The Company will host a conference call for the investment community at 9:30am ET to discuss the results. The call will also be available to the general public via a live audio webcast. Participants who wish to ask questions may register for the call at the following URL to receive the dial-in numbers and unique PIN: https://register.vevent.com/register/BI5c6e81632d434791b1b558bea845af36. It is recommended that participants join 10 minutes prior to the event start, although they may register ahead...

DURHAM, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that it has been selected to join the Medical CBRN Defense Consortium (MCDC), a key organization advancing the development of medical countermeasures and related technologies to protect U.S. military personnel and civilians from chemical, biological, radiological, and nuclear (CBRN) threats. The MCDC, established in 2015 under the U.S. Department of Defense (DoD), serves as a collaborative framework for government, industry, and academia to partner on cutting-edge medical solutions. Its mission is to rapidly advance research, development, and manufacturing of technologies that safeguard national security....

Post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg efzofitimod and placebo) groups. 54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compared to 7.7% in the therapeutic group. SAN DIEGO, Oct. 02, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the publication of a post hoc analysis of the Phase 1b/2a clinical trial of its lead therapeutic candidate, efzofitimod, in patients with pulmonary sarcoidosis, a major form of interstitial...

– Patients Prescribed Bempedoic Acid, As Well As Bempedoic Acid and Ezetimibe, With or Without Other Lipid Lowering Therapies, Showed A One-Third Relative Reduction in Low-Density LDL-C From Pre-Treatment To 2-Years in the MILOS Study – – Real-World Results Demonstrated ~7-Fold Increase in Proportion of Patients Achieving LDL-C Goals When Treated With Bempedoic Acid or Bempedoic Acid and Ezetimibe – – Data From the MILOS German Cohort Showed Bempedoic Acid, Alone or With Ezetimibe, Was Effective and Had A Safety Profile in Real-World Settings Consistent With the CLEAR Outcomes Study – ANN ARBOR, Mich., Oct. 02, 2024 (GLOBE NEWSWIRE) — Esperion (Nasdaq: ESPR) today announced that its European partner, Daiichi Sankyo Europe (DSE), reported final 2-year follow-up data from the German cohort of the multinational, European observational...

PURCHASE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs to treat neurodegenerative disorders, today announced the Company’s president and CEO Lisa Ricciardi will participate in a panel discussion titled Frontiers in Neuroscience during the 3rd Annual Roth Healthcare Opportunities Conference on October 9, 2024. Ms. Ricciardi also will host one-on-one investor meetings during which she will highlight recent achievements and clinical development plans for CT1812, the Company’s lead candidate for the treatment of Alzheimer’s disease, dementia with Lewy bodies, and dry age-related macular degeneration.   Investors interested in participating in the event and meeting with the Cognition team should contact their Roth Capital...

Appointment bolsters business development group’s expertise and industry knowledge of advanced materials, nanotechnology and electronic materials, and strengthens UK presence TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (the “Company” or “HydroGraph”), a sustainable commercial manufacturer of pristine graphene, is pleased to announce the appointment of Tom Eldridge to the role of Director of Business Development. Based in the UK, Tom will be responsible for spearheading business development activities, supporting customer projects, forging new strategic partnerships, and growing sales across crucial markets. He will focus on introducing HydroGraph’s pristine graphene to businesses looking to solve their critical needs through material innovations, while collaborating...

ROUYN-NORANDA, Quebec, Oct. 02, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that it will undertake a drilling program to enhance the deep mining potential of the Sleeping Giant mine. The 3D model of the mineral resource estimate made by InnovExplo in December 2022 shows the presence of several high-grade mineralized veins towards the lower levels of the mine. The Preliminary Economic Assessment carried out by InnovExplo in June 2023 made it possible to optimize several production sites in the same sector. Several of these workings belong to the 785N zone located east of the mine at the bottom of level 785. (figure 1). Figure 1: Location of 785N Zone.The 785N zone is made up of several parallel mineralized veins oriented north south. The dip...